Methods: In Cho Ray hospital evaluating for Acute myocardial infarction with renal impairment patients (creatinine clearance [eGFR] <60 mL / min) who received at least three renally adjusted therapeutic doses of enoxaparin and had steady-state antifactor Xa peak levels collected between Oct 2020 and Jun 2021.